- Home
- Publications
- Publication Search
- Publication Details
Title
New Insights in Thyroid Cancer and p53 Family Proteins
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 6, Pages 1325
Publisher
MDPI AG
Online
2017-06-22
DOI
10.3390/ijms18061325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYH9 binds to lncRNA genePTCSC2and regulatesFOXE1in the 9q22 thyroid cancer risk locus
- (2017) Yanqiang Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p53 family interactions and yeast: together in anticancer therapy
- (2016) Sara Gomes et al. DRUG DISCOVERY TODAY
- Tumour suppressive function of HUWE1 in thyroid cancer
- (2016) Weiyuan Ma et al. JOURNAL OF BIOSCIENCES
- Oncogenic Intra-p53 Family Member Interactions in Human Cancers
- (2016) Maria Ferraiuolo et al. Frontiers in Oncology
- Zn(II)-curc targets p53 in thyroid cancer cells
- (2015) ALESSIA GARUFI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Genetic Predisposition to Papillary Thyroid Carcinoma: Involvement ofFOXE1,TSHR, and a Novel lincRNA Gene,PTCSC2
- (2015) Huiling He et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- TSH overcomes Braf V600E -induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer
- (2015) M Zou et al. ONCOGENE
- Somatic Mutations ofFOXE1in Papillary Thyroid Cancer
- (2015) Michael Mond et al. THYROID
- SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways
- (2015) Elisa Stellaria Grassi et al. Oncotarget
- PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration
- (2015) Gennaro Chiappetta et al. Oncotarget
- Follicular cell-derived thyroid cancer
- (2015) Henning Dralle et al. Nature Reviews Disease Primers
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
- (2014) Nishant Agrawal et al. CELL
- The PTTG1-Binding Factor (PBF/PTTG1IP) Regulates p53 Activity in Thyroid Cells
- (2014) Martin L. Read et al. ENDOCRINOLOGY
- How theTP53Family ProteinsTP63andTP73Contribute to Tumorigenesis: Regulators and Effectors
- (2014) Eleonora Candi et al. HUMAN MUTATION
- PRIMA-1 Selectively Induces Global DNA Demethylation in p53 Mutant-Type Thyroid Cancer Cells
- (2014) Wei Qiang et al. Journal of Biomedical Nanotechnology
- The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth
- (2014) Eric Weinlander et al. JOURNAL OF SURGICAL RESEARCH
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53
- (2014) Jianhong Zhang et al. Nature Communications
- A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
- (2013) S. M. Lim et al. ANNALS OF ONCOLOGY
- An update on molecular biology of thyroid cancers
- (2013) Ozgur Omur et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
- (2013) Alan L. Ho et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Experience With Proteasome Inhibitor Treatment of Radioiodine Nonavid Thyroid Cancer Using Bortezomib
- (2012) Daniel Putzer et al. CLINICAL NUCLEAR MEDICINE
- Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma
- (2012) A. Altmann et al. JOURNAL OF NUCLEAR MEDICINE
- IRF5 promotes the proliferation of human thyroid cancer cells
- (2012) Michele Massimino et al. Molecular Cancer
- The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression
- (2012) H Bernard et al. ONCOGENE
- Expression of Cytokeratin 19 and Protein p63 in Fine Needle Aspiration Biopsy of Papillary Thyroid Carcinoma
- (2011) Mariella Bonzanini et al. ACTA CYTOLOGICA
- p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53
- (2011) G Melino CELL DEATH AND DIFFERENTIATION
- Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells
- (2011) Rosa Linda Messina et al. INTERNATIONAL JOURNAL OF CANCER
- HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage
- (2011) C Lazzari et al. ONCOGENE
- The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas
- (2011) Luca Lavra et al. PLoS One
- In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription
- (2011) Cinzia Puppin et al. CELLULAR ONCOLOGY
- p53-family proteins and their regulators: hubs and spokes in tumor suppression
- (2010) L Collavin et al. CELL DEATH AND DIFFERENTIATION
- Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer
- (2010) Mingzhao Xing THYROID
- Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005
- (2009) Amy Y. Chen et al. CANCER
- The multifaceted role of periostin in tumorigenesis
- (2009) Kai Ruan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules
- (2009) Yuri E. Nikiforov et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors
- (2009) Iñigo Landa et al. PLoS Genetics
- ΔNp73α inhibits PTEN expression in thyroid cancer cells
- (2008) Veronica Vella et al. INTERNATIONAL JOURNAL OF CANCER
- High periostin expression correlates with aggressiveness in papillary thyroid carcinomas
- (2008) Cinzia Puppin et al. JOURNAL OF ENDOCRINOLOGY
- Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties
- (2008) Andrea Prodosmo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Gal-3is stimulated by gain-of-functionp53mutations and modulates chemoresistance in anaplastic thyroid carcinomas
- (2008) Luca Lavra et al. JOURNAL OF PATHOLOGY
- TAp73 Increases p53 Tumor Suppressor Activity in Thyroid Cancer Cells via the Inhibition of Mdm2-Mediated Degradation
- (2008) R. Malaguarnera et al. MOLECULAR CANCER RESEARCH
- C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity
- (2008) M. Sauer et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started